Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Amal Abedrabbo"'
Autor:
Bassam Abu-Libdeh, Abdulsalam Abu-Libdeh, Eran Lavi, Yaniv Faingelernt, Alon Haim, Sara Abu-Rmaileh Amro, Raz Zarivach, David Zangen, Amal Abedrabbo, Ruti Parvari, Eli Hershkovitz
Publikováno v:
American Journal of Medical Genetics Part A. 185:1033-1038
Aldosterone synthase deficiency (ASD) is a rare potentially life-threatening genetic disorder that usually presents during infancy due to pathogenic variants in the CYP11B2 gene. Knowledge about CYP11B2 variants in the Arab population is scarce. Here
Autor:
Mary E. Velthuizen, Amal Abedrabbo, Demetra Georgiou, Ala I. Sharara, Keivan Majidzadeh-A, Carol Jabari, Laila Rifai, Andreas Hadjisavvas, Fahd Al-Mulla, Hans F. A. Vasen, Zeinab Ghorbanoghli, Rihab Ben Sghaier, Suzan M Talaat, Rania Abu Seir, Gurbankhan Muslumov, Wail Hammoudeh, Maria A. Loizidou, Hadia Ziada-Bouchaar, George Cortas, Berrin Tunca, Makia J. Marafie, Aysel Ahadova, Waseem Hamoudi, Ladan Goshayeshi, Marie-Pierre Buisine, Mohammad Sina
Publikováno v:
Familial Cancer, 20, 215-221. SPRINGER
Familial Cancer
Familial Cancer
Background Lynch syndrome (LS), the most common inherited form of colorectal cancer (CRC), is responsible for 3% of all cases of CRC. LS is caused by a mismatch repair gene defect and is characterized by a high risk for CRC, endometrial cancer and se
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a90eb967f7206c8653eb4ab4f227ba8
https://link.springer.com/article/10.1007/s10689-020-00211-3
https://link.springer.com/article/10.1007/s10689-020-00211-3
Autor:
Hamid Reza Khorram Khorshid, Ala I. Sharara, Ijad Hourani, Waseem Hamoudi, Nurdan Tözün, Osama Diab, Hadia Ziada-Bouchaar, Henry T. Lynch, George Cortas, Hans F. A. Vasen, Wail Hammoudeh, Bahareh Mahjoubi, Zeinab Ghorbanoghli, Amal Abedrabbo, Carol Jabari, Walid Sweidan, Keivan Majidzadeh
Publikováno v:
Familial Cancer
Colorectal cancer (CRC) has a very high incidence in the western world. Data from registries in the Middle East showed that the incidence of CRC is relatively low in these countries. However, these data also showed that CRC incidence has increased su
Autor:
Sforza, Daniele, Lenci, Ilaria, Manuelli, Matteo, Cento, Valeria, Rendina, Maria, Maria, Francesca Donato, Martina, Milana, Marianna, Aragri, Velia, Chiara Di Maio, Amal, Abedrabbo, Federico, Malinverno, Sara, Monico, Maria, Laura Ponti, Roberta, Canu, Roberto, Ganga, Milanesi, Luciano, Di Leo, Alfredo, Perno, Carlo Federico, Ceccherini-Silberstein, Francesca, Colombo, Massimo, Angelico, Mario, Tisone, Giuseppe
Publikováno v:
Transplant international 28 (2015): 22–23.
info:cnr-pdr/source/autori:Sforza, Daniele; Lenci, Ilaria; Manuelli, Matteo; Cento, Valeria; Rendina, Maria; Maria, Francesca Donato; Martina, Milana; Marianna, Aragri; Velia, Chiara Di Maio; Amal, Abedrabbo; Federico, Malinverno; Sara, Monico; Maria, Laura Ponti; Roberta, Canu; Roberto, Ganga; Milanesi, Luciano; Di Leo, Alfredo; Perno, Carlo Federico; Ceccherini-Silberstein, Francesca; Colombo, Massimo; Angelico, Mario; Tisone, Giuseppe/titolo:SLOW ACHIEVEMENT OF HCV-RNA UNDETECTABILITY IN CIRRHOTIC PATIENTS TREATED WITH SOFOSBUVIR plus RIBAVIRIN: POSSIBLE CLINICAL IMPLICATIONS IN THE LIVER TRANSPLANT LIST MANAGEMENT/doi:/rivista:Transplant international/anno:2015/pagina_da:22/pagina_a:23/intervallo_pagine:22–23/volume:28
info:cnr-pdr/source/autori:Sforza, Daniele; Lenci, Ilaria; Manuelli, Matteo; Cento, Valeria; Rendina, Maria; Maria, Francesca Donato; Martina, Milana; Marianna, Aragri; Velia, Chiara Di Maio; Amal, Abedrabbo; Federico, Malinverno; Sara, Monico; Maria, Laura Ponti; Roberta, Canu; Roberto, Ganga; Milanesi, Luciano; Di Leo, Alfredo; Perno, Carlo Federico; Ceccherini-Silberstein, Francesca; Colombo, Massimo; Angelico, Mario; Tisone, Giuseppe/titolo:SLOW ACHIEVEMENT OF HCV-RNA UNDETECTABILITY IN CIRRHOTIC PATIENTS TREATED WITH SOFOSBUVIR plus RIBAVIRIN: POSSIBLE CLINICAL IMPLICATIONS IN THE LIVER TRANSPLANT LIST MANAGEMENT/doi:/rivista:Transplant international/anno:2015/pagina_da:22/pagina_a:23/intervallo_pagine:22–23/volume:28
Sofosbuvir (SOF) treatment ± ribavirin (RBV) prior to LT has the potential to change the HCV recurrence after Liver Transplantation (LT). This approach has been reported to avoid graft reinfection in compensated patients with hepatocellular carcinom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=cnr_________::5f58904404566901e838ed0a7393e0ac
http://www.cnr.it/prodotto/i/361408
http://www.cnr.it/prodotto/i/361408